Vontobel Holding Ltd. Acquires 601 Shares of Tempus AI, Inc. $TEM

Vontobel Holding Ltd. grew its holdings in Tempus AI, Inc. (NASDAQ:TEM) by 12.8% in the 2nd quarter, Holdings Channel reports. The fund owned 5,285 shares of the company’s stock after purchasing an additional 601 shares during the quarter. Vontobel Holding Ltd.’s holdings in Tempus AI were worth $336,000 at the end of the most recent quarter.

Other large investors also recently modified their holdings of the company. Pathway Capital Management LP bought a new stake in shares of Tempus AI in the first quarter worth about $8,576,000. Sumitomo Mitsui Trust Group Inc. grew its holdings in shares of Tempus AI by 31.4% during the first quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company’s stock worth $205,284,000 after buying an additional 1,016,384 shares in the last quarter. Massachusetts Financial Services Co. MA raised its position in Tempus AI by 92.6% in the 1st quarter. Massachusetts Financial Services Co. MA now owns 578,890 shares of the company’s stock valued at $27,926,000 after buying an additional 278,311 shares during the last quarter. Cambridge Investment Research Advisors Inc. bought a new stake in Tempus AI in the 1st quarter valued at approximately $1,019,000. Finally, ARK Investment Management LLC boosted its position in Tempus AI by 35.9% during the 1st quarter. ARK Investment Management LLC now owns 7,501,399 shares of the company’s stock worth $361,867,000 after acquiring an additional 1,981,755 shares during the last quarter. 24.22% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of equities analysts have weighed in on TEM shares. HC Wainwright upped their price target on Tempus AI from $90.00 to $98.00 and gave the stock a “buy” rating in a research report on Friday, September 12th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Tempus AI in a research report on Wednesday, October 8th. Piper Sandler reaffirmed a “neutral” rating on shares of Tempus AI in a research report on Friday, August 8th. Morgan Stanley upped their price target on Tempus AI from $65.00 to $68.00 and gave the stock an “overweight” rating in a research report on Tuesday, August 12th. Finally, BTIG Research upped their price target on Tempus AI from $75.00 to $85.00 and gave the stock a “buy” rating in a research report on Wednesday, August 20th. Seven research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $71.83.

Tempus AI Price Performance

Shares of TEM opened at $89.87 on Wednesday. The firm has a market capitalization of $15.61 billion, a PE ratio of -75.52 and a beta of 4.87. The company’s 50-day moving average is $80.27 and its 200-day moving average is $65.36. Tempus AI, Inc. has a fifty-two week low of $31.36 and a fifty-two week high of $104.32. The company has a debt-to-equity ratio of 2.58, a current ratio of 1.54 and a quick ratio of 1.43.

Tempus AI (NASDAQ:TEM) last issued its quarterly earnings data on Friday, August 8th. The company reported ($0.22) earnings per share for the quarter, beating the consensus estimate of ($0.23) by $0.01. The company had revenue of $314.64 million for the quarter, compared to analyst estimates of $296.84 million. Tempus AI had a negative net margin of 20.98% and a negative return on equity of 122.86%. The company’s revenue was up 89.5% on a year-over-year basis. During the same period in the prior year, the firm earned ($6.86) earnings per share. Tempus AI has set its FY 2025 guidance at EPS. Equities analysts forecast that Tempus AI, Inc. will post -6.15 EPS for the current year.

Insider Buying and Selling at Tempus AI

In other Tempus AI news, EVP Erik Phelps sold 3,664 shares of Tempus AI stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $74.65, for a total value of $273,517.60. Following the completion of the transaction, the executive vice president directly owned 94,115 shares of the company’s stock, valued at $7,025,684.75. The trade was a 3.75% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CFO James William Rogers sold 7,528 shares of Tempus AI stock in a transaction on Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total value of $561,965.20. Following the completion of the transaction, the chief financial officer directly owned 138,473 shares of the company’s stock, valued at $10,337,009.45. This represents a 5.16% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 933,662 shares of company stock worth $68,070,993 in the last 90 days. Company insiders own 26.27% of the company’s stock.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.